Healthcare Journey

An Exciting Start 1971 - 1981

  • Late Dr. Vinod Daftary opens a blood bank.
  • An injection that helps RH-blood group women become mothers is launched.
  • Took our expertise one step ahead by exporting polyclonal sera.
  • Commissioned a plant in Thane.
  • Launched indigenously developed Plasma Fractions

R&D Takes Centre Stage 1981 - 2000

  • R&D recognition from Dept. of Scientific & Industrial Research, Govt. of India.
  • Launched India's first immunoglobulin against pseudomonas infection.

Global Footprint 2001 - 2011

  • EU & US FDA approved facility in Germany.
  • Started Operations in the Philippines-as a wholly owned subsidiary
  • Manufacturing facility at Ambernath near Mumbai opens.
  • Patent filing started - we have 15 product patents in India & globally.
  • Launched recombinant hormone for stimulating ovarian follicular growth to tackle infertility issues.

On a Fast-Track 2012 - 2016

  • Frost and Sullivan acknowledges BSV as the fastest-growing biotech company.
  • Launched a cure for sepsis and acute pancreatitis.
  • 62 products in the domestic market, 32 globally.
  • ISO 45001:2018 (Occupational Health & Safety Management System).
  • ISO 14001:2015 (Environment Management System).
  • Ranked amongst Top 10 biopharmaceutical companies by Biospectrum.
  • Anti-RhD global patent granted.
  • Launched Recombinant Anti-D

Setting Benchmarks in Healthcare 2017 - 2020

  • Advent International buys majority stake.
  • Strategic acquisition of Malaysian entity to solidify our position and expertise in the IVF segment.
  • Launched GTM initiatives in 17 countries with a dedicated field force on ground, significantly expanding our global market presence.
  • Ambernath plant gains approval from EU GMP from Halmed & Brazil ANVISA.
  • ISO 9001:2015 (Quality Management System).

Creating a Sustainable, Future-ready healthcare 2021 - Now

2021 - Now
  • BSV acquires TTK Healthcare's Human Pharma business.
  • Grew our global footprint in Malaysia by acquiring Firstline Pharmaceuticals Sdn. Bhd and Genomicks Sdn Bhd.
  • Ambernath Manufacturing facility opens Animal Testing Facility and Quality Control Laboratory.
  • Ground breaking of new manufacturing plant at Genome Valley, Telangana, India.
  • Introduction of  Adverse Event Reporting application : A pivotal stride in strengthening patient safety.
  • Ambernath Manufacturing facility certified as PIC/s GMP Compliant by State Service of Ukraine on Medicines and Drugs Control.